Clinical Trials Browser

Hyperinsulinism, Motor Activity, Obesity

NCT06742710 2025-05-29

LITOP

Phase 4 Recruiting

890 enrolled

Other

Infertility, Obesity, Polycystic Ovary Syndrome

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Phase 2/3 Recruiting

30 enrolled

Other

Obesity, Polycystic Ovary Syndrome

NCT04116203 2025-02-28

PCOS

Phase 1 Completed

52 enrolled

Other

Cardiovascular Diseases, Diabetes Mellitus, Obesity, Polycystic Ovary Syndrome, Lipid Metabolism Disorders

NCT06775093 2025-01-14

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

Phase NA Not yet recruiting

392 enrolled

Other

Infertility, Female, Obesity, Polycystic Ovary Syndrome

NCT05702905 2024-03-25

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Phase 4 Unknown

75 enrolled

Other

Obesity, Polycystic Ovary Syndrome

NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Phase 4 Completed

70 enrolled 11 charts

Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT01422746 2023-10-27

Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Phase EARLY_PHASE1 Unknown

20 enrolled

Other

Obesity, Polycystic Ovary Syndrome

NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Phase 3 Unknown

188 enrolled

Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Phase 3 Completed

119 enrolled 34 charts

Other

Obesity, Polycystic Ovary Syndrome

NCT01302379 2020-06-05

Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors

Phase NA Completed

333 enrolled 17 charts

BreastOther

Breast Neoplasms, Obesity, Weight Loss

NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

Phase 4 Completed

183 enrolled

Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT01793948 2018-03-30

Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

Phase EARLY_PHASE1 Completed

24 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT02280057 2017-02-23

Trial With Metformin in Women With Polycystic Ovary Syndrome

Phase 4 Completed

56 enrolled

Other

Obesity, Polycystic Ovary Syndrome

NCT02909933 2016-09-21

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

Phase 4 Completed

30 enrolled

Other

Obesity, Polycystic Ovary Syndrome

NCT00933309 2016-02-19

The Impact of Obesity and Obesity Treatments on Breast Cancer

Phase 1 Completed

25 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT00883259 2013-04-08

Metformin and Gestational Diabetes in High-risk Patients: a RCTs

Phase 4 Unknown

80 enrolled

Other

Obesity, Polycystic Ovary Syndrome, Pregnancy Complications, Diabetes, Gestational

NCT01410604 2012-04-27

Adipokines in Obese Adolescents With Insulin Resistance

Phase 4 Completed

31 enrolled 15 charts

Other

Insulin Resistance, Obesity

Clinical Trials

An Endometrial Cancer Chemoprevention Study of Metformin

LITOP

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

PCOS

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

Trial With Metformin in Women With Polycystic Ovary Syndrome

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

The Impact of Obesity and Obesity Treatments on Breast Cancer

Metformin and Gestational Diabetes in High-risk Patients: a RCTs

Adipokines in Obese Adolescents With Insulin Resistance